Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NICHOLAS ROHS

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1215226824
CMS profile
1383061
Location
NEW YORK, NY

General Payments · PY2018–2024

$169,009.33

  • Reported across 169 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$14,702.94

25 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $13,043.00 6
Food and Beverage $1,493.89 16
Education $108.18 2
Travel and Lodging $57.87 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $5,803.81 6
Regeneron Pharmaceuticals, Inc. $5,641.47 11
Genentech USA, Inc. $1,507.97 2
Daiichi Sankyo Inc. $1,484.72 2
JAZZ PHARMACEUTICALS INC. $156.79 2
PFIZER INC. $108.18 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $37,289.03 43
PY2019 $32,410.30 51
PY2020 $27,474.54 12
PY2021 $14,770.65 11
PY2022 $21,872.62 13
PY2023 $20,489.25 14
PY2024 $14,702.94 25

Payment records · PY2024 (25)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $23.22 06/02/2024 Food and Beverage Undisputed 01/23/2026 1105816185 CMS
AstraZeneca Pharmaceuticals LP $71.85 06/02/2024 Food and Beverage Undisputed 01/23/2026 1105861860 CMS
AstraZeneca Pharmaceuticals LP $3,330.00 07/25/2024 Consulting Fee Undisputed 01/23/2026 1104345880 CMS
AstraZeneca Pharmaceuticals LP $58.53 09/08/2024 Food and Beverage Undisputed 01/23/2026 1104495472 CMS
AstraZeneca Pharmaceuticals LP $100.21 09/08/2024 Food and Beverage Undisputed 01/23/2026 1105243275 CMS
AstraZeneca Pharmaceuticals LP $2,220.00 10/21/2024 Consulting Fee Undisputed 01/23/2026 1105466425 CMS
Daiichi Sankyo Inc. $1,455.00 02/21/2024 Consulting Fee Undisputed 01/23/2026 1089475629 CMS
Daiichi Sankyo Inc. $29.72 09/28/2024 Food and Beverage Undisputed 01/23/2026 1089475627 CMS
Genentech USA, Inc. $82.97 11/03/2024 Food and Beverage Undisputed 01/23/2026 1133080987 CMS
Genentech USA, Inc. $1,425.00 11/03/2024 Consulting Fee Undisputed 01/23/2026 1133080991 CMS
JAZZ PHARMACEUTICALS INC. $38.41 06/02/2024 Food and Beverage Undisputed 01/23/2026 1150204710 CMS
JAZZ PHARMACEUTICALS INC. $118.38 09/08/2024 Food and Beverage Undisputed 01/23/2026 1150204712 CMS
PFIZER INC. $54.09 03/15/2024 Education Undisputed 01/23/2026 1131256006 CMS
PFIZER INC. $54.09 03/15/2024 Education Undisputed 01/23/2026 1131256011 CMS
Regeneron Pharmaceuticals, Inc. $141.08 08/01/2024 Food and Beverage Undisputed 01/23/2026 1114404097 CMS
Regeneron Pharmaceuticals, Inc. $153.50 08/01/2024 Food and Beverage Undisputed 01/23/2026 1114404099 CMS
Regeneron Pharmaceuticals, Inc. $105.45 08/01/2024 Food and Beverage Undisputed 01/23/2026 1114404101 CMS
Regeneron Pharmaceuticals, Inc. $148.04 08/01/2024 Food and Beverage Undisputed 01/23/2026 1114404103 CMS
Regeneron Pharmaceuticals, Inc. $150.01 08/01/2024 Food and Beverage Undisputed 01/23/2026 1114404105 CMS
Regeneron Pharmaceuticals, Inc. $3,295.00 08/02/2024 Consulting Fee Undisputed 01/23/2026 1114404107 CMS
Regeneron Pharmaceuticals, Inc. $1,318.00 08/02/2024 Consulting Fee Undisputed 01/23/2026 1114404109 CMS
Regeneron Pharmaceuticals, Inc. $57.87 08/02/2024 Travel and Lodging Undisputed 01/23/2026 1114404111 CMS
Regeneron Pharmaceuticals, Inc. $113.59 08/14/2024 Food and Beverage Undisputed 01/23/2026 1114404113 CMS
Regeneron Pharmaceuticals, Inc. $64.27 08/14/2024 Food and Beverage Undisputed 01/23/2026 1114404115 CMS
Regeneron Pharmaceuticals, Inc. $94.66 08/14/2024 Food and Beverage Undisputed 01/23/2026 1114404117 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.